Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases

• 收藏
• 分享

专利权人:

Bristol-Myers Squibb Company

发明人:

Jure-Kunkel, Maria,Lee, Francis Y.

申请号：

AU2009350151

公开号：

AU2009350151A1

申请日:

2009.10.29

申请国别(地区):

AU

年份:

2012

代理人:

摘要：

Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders. Such Compositions comprise inter alia an anti-CTLA-4 agent, e.g. ipilimumab or tremelimumab in combination with other chemotherapeutic agents such as dasatinib, imatinib, paclitaxel, gemcitabine, cisplatin or etoposide.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/